Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MSX1-expression during the different phases in healthy human endometrium.
Eppich S, Kuhn C, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Gallwas J, Heidegger HH. Eppich S, et al. Among authors: gallwas j. Arch Gynecol Obstet. 2023 Jul;308(1):273-279. doi: 10.1007/s00404-023-07033-5. Epub 2023 Apr 27. Arch Gynecol Obstet. 2023. PMID: 37101223 Free PMC article.
Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers.
Ochsenkühn R, Arzberger A, von Schönfeldt V, Gallwas J, Rogenhofer N, Crispin A, Thaler CJ, Noss U. Ochsenkühn R, et al. Among authors: gallwas j. Fertil Steril. 2012 Aug;98(2):347-54. doi: 10.1016/j.fertnstert.2012.04.041. Epub 2012 May 24. Fertil Steril. 2012. PMID: 22633265 Free article. Clinical Trial.
[Changes to cervical cancer screening in Germany].
Starrach T, Gallwas J, Blankenstein T, Mahner S, Dannecker C. Starrach T, et al. Among authors: gallwas j. MMW Fortschr Med. 2018 Feb;160(2):46-51. doi: 10.1007/s15006-018-0152-6. MMW Fortschr Med. 2018. PMID: 29417509 Review. German. No abstract available.
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
Semmlinger A, von Schoenfeldt V, Wolf V, Meuter A, Kolben TM, Kolben T, Zeder-Goess C, Weis F, Gallwas J, Wuerstlein R, Hermelink K, Schmoeckel E, Harbeck N, Mayr D, Mahner S, Jeschke U, Ditsch N. Semmlinger A, et al. Among authors: gallwas j. BMC Cancer. 2018 Apr 16;18(1):431. doi: 10.1186/s12885-018-4286-9. BMC Cancer. 2018. PMID: 29661238 Free PMC article.
75 results